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Objective. To report on a multifaceted approach to increase uptake of the H1N1 vaccine in our ethnically diverse obstetrical
population. Methods. A review of our obstetric clinic vaccine registry and the approaches used to increase vaccine uptake. We
created areal-timevaccineregistry, educated patientsintheirownlanguageviaeducationalvideosanduseofculturalcaseworkers,
facilitatedpatientappointmentsandtransportation,educatedstaﬀ,andusedotherinterventionstoenhanceimmunizationuptake.
Results. Within the ﬁrst month of H1N1 availability, we vaccinated 120 of our total 157 obstetrics patients. Our overall coverage
rate was 76% (number vaccinated/total number eligible.) Of the enrolled patients, the vaccine acceptance rates were similarin our
English (59 (78%) of 76) versus non-English (59 (75%) of 79) speaking patients. Conclusions. High vaccine coverage is possible in
an ethnically diverse, highly immigrant obstetrics population.
1.Introduction
Pregnant women are known to be at increased risk for poor
maternal and pregnancy outcomes with inﬂuenza [1]a n d
are designated as a “high-risk” or priority population for
receiving the inﬂuenza vaccine. Both the Advisory Commit-
tee onImmunization and Practices(ACIP) forthe Centerfor
Disease Control and Preventionand the American College of
Obstetrics and Gynecology recommend immunization of all
w o m e nw h oa r ep r e g n a n td u r i n gﬂ us e a s o ni na n yt r i m e s t e r .
Despiteinclusionofseasonal inﬂuenzavaccineas anessential
element of prenatal care [2], coverage rates have remained
low and, in 2008-2009, the seasonal inﬂuenza vaccination
rate in pregnant women was reported to be 11.3% [3].
A paucity of data exists as to the reasons for low vaccine
coverage in an obstetric population. Many obstetric health
care workers lack knowledge regarding the safety and clinical
importance of inﬂuenza vaccine for pregnant women [4–
6]. Studies are few addressing the relationship of obstet-
ric patient population characteristics and immunization
acceptance, and no data has addressed immunization accep-
tance in an immigrant obstetric population.
In2009,anovelinﬂuenzaA(H1N1)virusofswine origin
causedhuman infection and acuterespiratory illness in Mex-
ico [1]. Rapid dissemination occurred and a pandemic was
declaredby theWorld Health Organization onJune 11, 2009.
Consistent with priorinﬂuenza pandemics,pregnant women
suﬀered disproportionally. In the United States, pregnant
women represent about 1 to 2% of the population but
accountedforupto7to10%ofthehospitalized patients,6to
9% of the ICU patients, and 6 to 10% of those patients who
died [1]. The quoted risk for hospitalization in pregnancy
is increased by a factor of 4 to 7 as compared with age-
matched nonpregnant women, with the highest risk in
the third trimester [1]. Once the H1N1 inﬂuenza vaccine
became available, CDC and ACOG strongly advised H1N1
vaccination for all pregnant women.
Our clinic serves an ethnically diverse obstetric popula-
tion. Many of our patients are recent immigrants unfamiliar
with Western medicine and do not speak English. Because2 Infectious Diseases in Obstetrics and Gynecology
little data is published about immunization interventions in
the population our clinic serves, we sought to analyze our
experience. The purpose of this paper is to document a
multifactorial highly successful inﬂuenza immunization pro-
gram in our largely immigrant and ethnically diverse obstet-
ric population.
2.Methods
2.1. Study Setting. The Harborview Medical Center (HMC)
is located in Seattle, Wash, and is one clinical site for the
University of Washington School of Medicine and serves an
ethnically diverse population. The HMC Women’s Clinic has
9 residents, 6 attendings, and one mid-level practitioner who
providedobstetriccarefor228pregnantwomenin2009.The
HMC clinic utilizes certiﬁed medical interpreters available in
person or by phone for patient visits. Additionally, the clinic
oﬀers cultural case workers who facilitate the integration of
recent immigrants into a new medical system. Each pregnant
patient is seen or oﬀered an appointment with a social
worker at least once during her pregnancy.
2.2. Study Design. This is a retrospective study of H1N1 vac-
cinecoverageachievedin theﬁrst monthofvaccineavailabil-
ity in 157 pregnant women. All pregnant patients enrolled
in our clinic at the time the vaccine became available on
October21st, 2009, were included.Using a standardized data
form we collected data regarding age, ethnic background,
spoken language, acceptance or refusal of the H1N1 vaccine,
whether patients required clinic or hospital evaluations
for inﬂuenza symptoms, and conﬁrmed cases of H1N1.
We linked clinic records to hospital records to determine
patientoutcomesandinﬂuenzahospitalizationandinﬂuenza
culture results. Our data was analyzed using Stata, and this
study was approved by IRB no. 38805 at the University of
Washington.
2.3. Interventions. Prior to vaccine availability we instituted
educational sessions for team members in our obstetrics
clinic. We presented data regarding the increased risk of
H1N1 in pregnant women, recommendations for the
inﬂuenza vaccine, and safety record of the vaccine. This
included staﬀ at our front desk, medical assistants, nurses,
and social workers. Medical interpreters were also invited
to attend. We planned future obstetrical visits to occur
within two weeks ofthe anticipated vaccine release. Once the
vaccine became available, patients were contacted personally
in their own language to encourage clinic attendance and
immunization, and those at or beyond 36 weeks gestation
were oﬀered taxi transportation.
We placed an inﬂuenza prevention video made by our
international medicine clinicin the waiting room that played
continuously in 9 languages to increase the awareness of the
inﬂuenza virus. It speciﬁcally discussed the importance of
preventative measures such as receiving the immunization,
symptoms, and receiving testing if our patients became
symptomatic. Written literature was provided to the patients
considering or receiving the vaccine. Patients were provided
within 2weeks
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Figure 1: Clinic interventions used to increase H1N1 vaccine cov-
erage.
“ﬂu packs” that contained masks, a digital thermometer, and
hand antiseptic.
We used dated H1N1 vaccine acceptance or refusal stick-
ers on the front of our obstetric patient charts to prompt
providers on the status of the patient. We created standing
orders for the H1N1 vaccine administration that were placed
in each chart to facilitate immunization at the time of the
scheduled visit. An electronic vaccine registry was created
by the nursing staﬀ and updated daily, which allowed the
clinic to easily identify the patients who had not yet received
their vaccine. Because we had “real-time” information on
vaccine administration, we were able to create electronic
schedule prompts to track the patient’s immunization status
(Figure 1).
3.Results
Within the ﬁrst month of vaccine availability, we immunized
120 (76%) of 157 enrolled obstetrical patients. Of the
remaining patients,17declined,5deliveredbeforetherelease
of the vaccine, 2 contracted H1N1, 9 were lost to care and
unreachable, and 9 planned to receive the vaccine at their
next appointment. Of the 9 who planned to receive the
vaccine at their next visit, 3 actually received it at their next
prenatalvisit,onepatientdeliveredatanoutsidehospitaland
receiveditwhentheyreturnedfortheirpostpartumvisit,and
ﬁve did not get the vaccine upon return. No adverse events
were documented in any of the patients who received the
H1N1 vaccine. We had three conﬁrmed cases of H1N1 in
our obstetric population. One of the three patients received
the H1N1 vaccine at 7-week gestation and contracted H1N1
7 days later. Of the two who did not receive the vaccine,
one contracted H1N1 8 days after H1N1 vaccine availability.
She had received the seasonal vaccine as this was available in
our clinic prior to the H1N1 vaccine. The second contractedInfectious Diseases in Obstetrics and Gynecology 3
Table 1: Demographic and outcome characteristics of vaccinated versus unvaccinated HMC obstetric patients.
Variable All patients
n = 157
Vaccine acceptance
n = 120 (76%)
Vaccine declination
n = 37 (24%) P value
Maternal age mean∗ 27.8 27.5 ± 6.1 28.7 ± 5.5 .346+
Gestational age mean∗ 23.6 23.9 ± 9.8 26.6 ±12.8 .195+
Ethnic populations∗∗
N = 154 .634++
African American 38 27 (71%) 11 (29%)
West/East African 70 52 (74%) 18 (26%)
Paciﬁc
Islander/Asian 9 7 (78%) 2 (22%)
Native American 2 2 (100%) 0 (0%)
Caucasian 19 17 (89%) 2 (11%)
Hispanic 16 13 (81%) 3 (19%)
Spoken language∗∗∗
N = 155
English 76 59 (77%) 17 (23%) .667++
Non-English 79 59 (75%) 20 (25%)
+T-test.
++Chi square.
∗n = 153 due to missing information regarding maternal and gestational age.
∗∗n = 154 due to missing information regarding ethnic background.
∗∗∗n = 155 due to missing information regarding spoken language.
H1N1at15-week gestational age,which was12 daysafter the
vaccine availability.
Demographic data for our study population are pre-
sented in Table 1. There was not a statistical diﬀerence in
maternal age or gestational age and vaccine acceptance. The
ethnic populations of the HMC obstetric patients who were
included in this research analysis were 24.6% African Amer-
ican, 45.5% West/East African, 5.8% Paciﬁc Islander/Asian,
1.3% Native American, 12.3% Caucasian, and 10.4% His-
panic. The acceptance rates across the diﬀerent ethnic popu-
l a t i o n sw e r e2 7( 7 1 % )o f3 8A f r i c a nA m e r i c a n ,5 2( 7 4 % )o f
70 West/East African, 7 (78%) of 9 Paciﬁc Islander/Asian, 2
(100%)of2NativeAmerican, 17(90%)of19Caucasian,and
13 (81%) of 16 Hispanic. There was no diﬀerence between
the acceptance rate across the diﬀerent ethnic populations
(P = .634).
In a typical month 46% of our visits are interpreted
visits. Vaccine acceptance was 59 (78%) of 76 in our English
speaking versus 59 (75%) of 79 in our non-English speaking
patients. We did not ﬁnd a diﬀerence among the acceptance
rateoftheH1N1vaccinein thisanalysis (P = .667)(Table1).
4.Conclusions
Our overall coverage rate of 76% (number vaccinated/total
number eligible) compares favorably to the nationwide 38%
coverage rate reported initially by the CDC and the 46.6%
reported more recently from 10 states using the Pregnancy
RiskAssessment MonitoringSystem(PRAMS)[7,8].Despite
inclusion of seasonal inﬂuenza vaccine as an essential
element of prenatal care [2], a reassuring safety proﬁle in all
trimesters of pregnancy [9, 10], and documented beneﬁt to
newborns and infants whose mothers receive the inﬂuenza
vaccinewhile pregnant[2,11–13],coverageratesofpregnant
women with seasonal inﬂuenza vaccine have been minimal
[3]. Cognizant of this historically low coverage rate, we
began planning weeks in anticipation of the vaccine to
i n s t i t u t em u l t i p l ei n t e r v e n t i o n s .W ew e r ea b l et od o c u m e n t
high H1N1 immunization acceptability and coverage levels
among our ethnically diverse obstetrics population.
Previous studies suggest that both obstetric and nonob-
stetric healthcare workers lack conﬁdence in the safety of
the inﬂuenza vaccine in pregnancy [6, 14, 15]. Additionally,
our oﬃce colleagues may be unaware of the distinct beneﬁt
inﬂuenza vaccination oﬀers mothers and infants. This led
us to proactively institute educational sessions for all of
our staﬀ prior to availability of the vaccine. We oﬀered a
straightforward message stressing 3 of the strong reasons
for immunizing all pregnant women with inﬂuenza vaccine:
pregnant women are more likely to acquire inﬂuenza after
an exposure, they become more sick when they contract
inﬂuenza, and immunizing the mother during pregnancy
decreases hospitalizations and respiratory illnesses in their
infants. The increased understanding and awareness among
our staﬀ of the importance and safety of inﬂuenza vacci-
nation in pregnant women encouraged a successful team
approach and is likely a key factor in achieving a high rate
of vaccine acceptance and administration.
The use of a vaccine registry has not been published in
an obstetric population but is used commonly in pediatric
populations and more recently in adult populations [16, 17].
Wedevelopedanelectronic vaccineregistry thatwasupdated
daily. This allowed us to target patients who had not received
the vaccine, anticipate their next appointment, and ensure4 Infectious Diseases in Obstetrics and Gynecology
all patients were oﬀered the vaccine in an expedited fashion.
In addition we had a sticker placed on each paper chart
to identify the exact date the vaccine was administered or
declined. With these tools, we could eﬃciently track and
communicate information regarding our patients’ vaccine
status. Automatic prompts are also available within many
electronic medical record systems. While these immediate
visual cues for the staﬀ and provider appeared to have
excellent utility in our clinic, research is needed to compare
the impact of various “triggers” on immunization rates.
Our clinic serves a multiethnic population. We searched
for published data on immunization programs in such a
patient population but found scant information was avail-
able to assist either providers or immunization program
managers in obstetric clinics who serve a multiethnic pop-
ulation. The CDC has demonstrated disparities in vaccina-
tion coverage among Hispanics and blacks [18]. Proposed
barriers to vaccination in these populations include ability
to access healthcare, language barriers, and fear of being
able to provide proof of legal status to obtain vaccination
[18]. In our diverse ethnic group, we found no diﬀerence in
vaccine acceptanceacross all our ethnic populationsbetween
English and non-English speaking patients, or between
country/culture of origin. We have excellent interpreter
services and were able to provide our patients with spoken
and written information in many languages. This ability
to communicate eﬀectively with our non-English speaking
patients undoubtedly contributed to the equivalent vaccine
coverage despite spoken language.
Increased media attention regarding H1N1 in 2009 both
encouraged and discouraged the use of immunization. We
are unable to separate out the impact of this strong media
attention versus our clinic eﬀorts in achieving high cover-
age. Before the vaccine was available, data conﬁrming the
increased risk of H1N1 in pregnant women was published
[1].Weeducatedpatientsusing standard safety messages and
emphasized the increased threat to pregnant patients with
the current season of H1N1. With some patients, lengthy
discussions of safety and testing of the vaccine were needed
to address the media reports of adverse events attributed
to both vaccine uses in general and the H1N1 vaccine in
particular.
This paper has several limitations. Our success is re-
ported from a single clinic which is ethnically diverse and
has the support of interpreter services and cultural case
workers which may limit the ability to generalize this study
to other clinics. We acknowledge that we instituted multiple
interventionssimultaneously.Whilewemayhypothesizethat
reaching out to our patients with culture case workers in
their own language or educating the staﬀ in the clinic may
be the most important variables, we are not able to delineate
the relative importance of each factor on vaccination rates
during the initial H1N1outbreak. Additionally, the hospital
allocated additional resources to our clinic including provi-
sion of inﬂuenza care packages, as well as increased staﬃng
to answer phone calls and triage patients. These additional
resources may have provided an improvement in vaccine
acceptability which is not sustainable. We have ongoing
monitoring to compare 2009 coverage rates with current
inﬂuenza immunization uptake now that we are not in a
nonpandemic setting. Lastly, we have no comparator clinic
where these interventions were not instituted.
Despite these limitations, we believe the success of this
multifaceted approach, with interventions designed, in part,
to target our highly diverse, immigrant obstetric population,
may provide a useful model for other clinics. Additionally,
we anticipate that this study may inform future research
trials designed to improve vaccine coverage in this typically
undervaccinated population.
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